p-T180,Y182-MAPK14 [cytosol]

Stable Identifier
R-HSA-428935
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
Phospho-MAP kinase p38 alpha, MAP kinase p38 alpha (activated), MAPK14, Mitogen-activated protein kinase 14, MK14_HUMAN, pp38 alpha
p-T180,Y182-MAPK14 [cytosol] icon
Locations in the PathwayBrowser for interactor UniProt:P52564 MAP2K6
Participates
Other forms of this molecule
Inferred To
Modified Residues
Name
O-phospho-L-threonine at 180
Coordinate
180
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.
Name
O4'-phospho-L-tyrosine at 182
Coordinate
182
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-tyrosine residue to O4'-phospho-L-tyrosine.
Cross References
ZINC - World Drugs
Guide to Pharmacology - Targets
OpenTargets
ZINC - FDA approved
ZINC - Substances
ZINC - Biogenic
ZINC target
PRO
GlyGen
PDB
3HP5, 5XYX, 4EWQ, 1WBN, 4EH3, 3FMN, 3MVM, 2LGC, 1WFC, 1ZYJ, 3ROC, 4KIN, 3HV3, 3CTQ, 4EH7, 4F9W, 5N66, 5OMG, 2BAQ, 3OC1, 6HWV, 3OBJ, 3NEW, 3OCG, 6M95, 4E5A, 4AAC, 5WJJ, 3IW8, 3ODY, 3GI3, 2YIX, 3D83, 5MTY, 3L8S, 5ETI, 2QD9, 4L8M, 3O8P, 3FKN, 3IPH, 3S4Q, 1W84, 3HEC, 5N65, 3FMK, 3L8X, 3FLZ, 3MPT, 6HWU, 3MW1, 3UVP, 4AA4, 3GCP, 3GFE, 4E5B, 1YQJ, 3NNW, 3ODZ, 3BX5, 3KQ7, 2Y8O, 3FMM, 3FMH, 4EHV, 3MVL, 2ONL, 5N63, 4EH6, 3IW6, 3OEF, 2YIS, 3GCV, 6TCA, 4A9Y, 8A8M, 3LFE, 3FKL, 4E6A, 6QE1, 3GC7, 3E92, 3MH2, 3HUB, 2YIW, 3U8W, 5N67, 3FC1, 4ZTH, 5ETF, 2GFS, 5TCO, 1R39, 3LFD, 3GCU, 3O8U, 3NNU, 4GEO, 5XYY, 3C5U, 1WBS, 5ETA, 3FLQ, 3IW7, 1WBV, 3DT1, 3LFF, 3FLY, 3FMJ, 1BL6, 9CJ3, 3E93, 3MH3, 6ANL, 3MGY, 6QDZ, 3HUC, 6QYX, 3KF7, 3HV6, 1R3C, 1IAN, 1M7Q, 3NWW, 3OD6, 3NNV, 3FSF, 6OHD, 1OUY, 3LHJ, 1WBO, 3ZYA, 3HEG, 2FSO, 3FLN, 1KV1, 1OUK, 8VXE, 3LFC, 2RG6, 3FLW, 3ITZ, 3HV5, 3FI4, 5TBE, 4F9Y, 3MH0, 3BV3, 3GCS, 3HP2, 1A9U, 5ETC, 4DLI, 6SFK, 2BAK, 4R3C, 6RFO, 9CJ5, 4AA0, 3HA8, 4EH5, 3IW5, 5N64, 2ZAZ, 6M9L, 3S3I, 3O8T, 9CJ2, 1WBW, 2RG5, 2OKR, 1BL7, 3OBG, 3ZSH, 3UVR, 3MH1, 3ZS5, 5OMH, 4EH2, 1DI9, 1BMK, 3HRB, 3RIN, 3MPA, 5MZ3, 3HL7, 4DLJ, 2BAJ, 8X3M, 6SFO, 6ZWP, 3HV7, 4EH4, 3FLS, 1ZZ2, 2NPQ, 2FSM, 5O8U, 1W7H, 1WBT, 3K3I, 3ZSI, 1ZZL, 1W83, 3LFA, 3HV4, 5O8V, 4KIP, 4EH8, 5ML5, 3HLL, 3FL4, 4AA5, 3GCQ, 2ZB0, 6SFJ, 3NNX, 3QUD, 2BAL, 3PG3, 6ZQS, 2I0H, 9CJ4, 5MTX, 1KV2, 2FST, 2FSL, 6HWT, 3FKO, 4E6C, 3K3J, 1OZ1, 3LFB, 1W82, 9CJ1, 4FA2, 3D7Z, 4E8A, 5N68, 3FML, 3UVQ, 3ZSG, 3BV2, 4EH9, 4KIQ, 3HVC, 2ZB1, 1OVE, 6SFI, 3QUE, 3FSK, 3DS6
ZINC - Investigational
ZINC - Metabolites
IntEnz
GeneCards
Pharos - Targets
ZINC - Predictions - Purchasable
HMDB Protein
Interactors (39)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P49137 MAPKAPK2  5 0.936 16
 UniProt:Q16644 MAPKAPK3  4 0.922 16
 UniProt:O75676 RPS6KA4  1 0.869 10
 UniProt:P46734 MAP2K3  3 0.802 7
 UniProt:Q9BUB5 MKNK1  1 0.798 7
 UniProt:O75147 OBSL1  1 0.788 5
 UniProt:Q9HBH9 MKNK2      0.788 5
 UniProt:Q99956 DUSP9  1 0.779 6
 UniProt:P28562 DUSP1  1 0.767 4
 UniProt:Q8NEM7 SUPT20H  1 0.756 5
 UniProt:Q9BY84 DUSP16  3 0.738 4
 UniProt:O43257 ZNHI1      0.72 7
 UniProt:Q15750 TAB1  6 0.713 4
 UniProt:P27361 MAPK3  6 0.691 5
 UniProt:Q15256 PTPRR      0.664 4
 UniProt:O75582 RPS6KA5  3 0.659 4
 UniProt:Q6PJG2 MDEAS      0.659 3
 UniProt:P46940 IQGAP1  3 0.643 4
 UniProt:Q9H0W5 CCDC8  1 0.643 3
 UniProt:P06400 RB1  20 0.623 4
 UniProt:Q16829 DUSP7  2 0.59 2
 UniProt:P52564 MAP2K6  3 0.564 3
 UniProt:P48730-2 CSNK1D      0.556 3
 UniProt:Q9H869 YYAP1      0.553 2
 UniProt:Q8IW41 MAPKAPK5  5 0.547 2
 UniProt:Q14814 MEF2D  1 0.547 2
 UniProt:Q15759 MAPK11  4 0.547 2
 UniProt:P68104 EEF1A1  7 0.547 3
 UniProt:P13639 EEF2  10 0.527 2
 UniProt:Q5VYV7 SLX4I      0.527 3
 UniProt:Q14999 CUL7  1 0.527 2
 UniProt:Q96RR4 CAMKK2  4 0.527 2
 UniProt:Q96CC6 RHDF1      0.527 2
 UniProt:Q15170 TCAL1      0.527 2
 UniProt:P78368 CSNK1G2  2 0.527 3
 UniProt:P51784 USP11  1 0.527 2
 UniProt:Q07352 ZFP36L1  3 0.508 2
 UniProt:Q92574 TSC1  2 0.508 2
 UniProt:Q969H0 FBXW7  1 0.471 5
Cite Us!